Director/PDMR Shareholding

By

Regulatory News | 11 Mar, 2020

Updated : 11:25

RNS Number : 7842F
Marlowe PLC
11 March 2020
 

11 March 2020

Marlowe plc

("Marlowe" or the "Group")

 

Director/PDMR Shareholding

 

Marlowe plc ("Marlowe" or the "Group"), the specialist services group focused on developing companies which assure safety and regulatory compliance, notifies that, on 11 March 2020, in order to effect a transfer between legal holdings, Alex Dacre (Chief Executive of the Group) sold 2,612,613 ordinary shares of 50 pence each in the capital of the Group ("Ordinary Shares") to Dacre Holdings Limited, a company wholly owned and controlled by Mr Dacre, at a price of 444 pence per Ordinary Share.

 

There is no change to Mr Dacre's beneficial interest in Ordinary Shares as a result of this transaction. Mr Dacre holds a beneficial interest in a total of 3,521,334 Ordinary Shares, representing approximately 7.7 per cent of the Company's issued share capital.

 

 

 

For further information:

www.marloweplc.com

 

 

Marlowe plc

0203 813 8498

Alex Dacre, Chief Executive

IR@marloweplc.com

Mark Adams, Group Finance Director

 

 

 

Cenkos Securities (Nominated Adviser & Joint Broker)

0207 397 8900

Nicholas Wells

Ben Jeynes

Harry Hargreaves

 

 

 

Joh. Berenberg, Gossler & Co. KG, London Branch (Joint Broker)

Ben Wright

Mark Whitmore

 

FTI Consulting

0203 207 7800

 

 

 

0203 727 1340

Nick Hasell

 

Alex Le May

 

 

 

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alex Dacre

2

Reason for the notification

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Sale of ordinary shares to effect transfer between legal holdings

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

444 pence

2,612,613

 

 

 

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

2,612,613

- Price

£11,600,001.72

e)

Date of the transaction

11 March 2020

f)

Place of the transaction

Outside trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dacre Holdings Limited

2

Reason for the notification

a)

Position/status

Person closely associated with Alex Dacre, Chief Executive

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Purchase of ordinary shares to effect transfer between legal holdings

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

444 pence

2,612,613

 

 

 

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

2,612,613

- Price

£11,600,001.72

e)

Date of the transaction

11 March 2020

f)

Place of the transaction

Outside trading venue

 

 


 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHZZGMFMMFGGZM

Last news